Rhaissa Calixto Vieira
About me
My work focuses on understanding how platelets act as immune regulators beyond hemostasis by interacting with leukocytes and modulating inflammation and immune responses. I work on developing therapeutic strategies for Wiskott–Aldrich syndrome (WAS)– related thrombocytopenia and inflammatory diseases.
Key highlights of my research:
• FACS High-throughput drug discovery: Engineered CRISPR-edited cell lines carrying patient-relevant WAS mutations and established a flow-cytometry–based screening platform (>7, 000 compounds) to identify small molecules that stabilize WASp.
• Translational platelet biology: Investigating how WASp deficiency alters platelet function and immune interactions in mouse models and patient samples.
• Advanced imaging & analysis: Extensive experience in confocal microscopy, for quantitative imaging of megakaryocyte maturation and platelet activation.
I’m excited about collaborations at the interface of immunology, hematology, and translational therapeutics, and I enjoy mentoring students and sharing science with the broader community.
Teaching
Project supervision
During my period working as a postdoctoral Researcher at Westerberg's Lab I was involved in the scientific training of students from Sweden and
abroad, as follows:
Sofie Hemström, medical undergrad from Karolinska Institutet
Period: June 7 to July 2, 2021
Project enrolled: Lipid Rafts and F-actin interplay in Megakaryocyte activation and platelet formation.
Marta Dominguez Gargallo, Biotechnology undergraduate from Barcelona University
Period: February to June 2022
Project enrolled: Flow cytometry-based drug repurposing screening for WASp stabilization in X-linked thrombocytopenia megakaryocytes.
Yeon Jae Lee, Biology student from New York /Abu Dhabi University
Period: July 1st to August 10, 2022
Project enrolled: Molecular Biology tools for Wiskott-Aldrich syndrome study.
Giulio Zanette, Master student from Trieste University
Period: February to October 2023
Project enrolled: Restoring platelets in WAS and XLT – mice model study.
Elisabet Jené Vinuesa, Biology undergrad from Barcelona University
Period: February to July 2023
Project enrolled: Compound validation for WASp stabilization in X-linked thrombocytopenia megakaryocytes.Isabella Rosales Enriquez, Biology undergrad from Strasbourg University
Period: January to June 2025
Project enrolled: Targeting platelet activation in Wiskott Aldrich Syndrome
Articles
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2024;54(5):e2350450Vasconcelos-Fontes L; Vieira RC; He M; Ferreira-Reis R; Jurberg AD; Mendes-da-Cruz DA; Andersson J; Cotta-de-Almeida V; Westerberg LS
- Article: JOURNAL OF VIROLOGY. 2023;97(1):e01752-e01722Temerozo JR; Ferreira PLC; Linhares-Lacerda L; Vieira RC; Cister-Alves B; Gobbo L; Ribeiro-Alves M; Menna-Barreto RFS; Bou-Habib DC
- Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2022;149(3):1069-1084He M; Saeed MB; Record J; Keszei M; Pinho LG; Vasconcelos-Fontes L; D'Aulerio R; Vieira R; Oliveira MMS; Geyer C; Bohaumilitzky L; Thiemann M; Deordieva E; Buedts L; Lopes JPM; Pershin D; Hammarstrom L; Xia Y; Zhao X; Cunningham-Rundles C; Thrasher AJ; Burns SO; Cotta-de-Almeida V; Liu C; Shcherbina A; Vandenberghe P; Westerberg LS
- Article: FRONTIERS IN IMMUNOLOGY. 2018;9:1336Temerozo JR; de Azevedo SSD; Insuela DBR; Vieira RC; Ferreira PLC; Carvalho VF; Bello G; Bou-Habib DC
All other publications
- Review: PEDIATRIC ALLERGY AND IMMUNOLOGY. 2023;34(4):e13951Vieira RC; Pinho LG; Westerberg LSS
Grants
- Israeli Wiskott Aldrich Syndrome fellowship - Drug screening to identify and test new compounds to stabilize WASp in XLT/WAS patientsIsraeli Wiskott Aldrich Syndrome - IWASA6 July 2020 - 30 June 2022